Evidence map›Paper›PMID 27274442›Full record

ReviewGMS hygiene and infection control2016

Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Arne Simon, Rhoikos Furtwängler, Norbert Graf, Hans Jürgen Laws, Sebastian Voigt, Brar Piening, Christine Geffers, Philipp Agyeman, Roland A Ammann

Abstract readReview
In one paragraph

Review in GMS hygiene and infection control, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Arne SimonPädiatrische Onkologie und Hämatologie, Universitätsklinikum des Saarlandes, Homburg, Germany.
Rhoikos FurtwänglerPädiatrische Onkologie und Hämatologie, Universitätsklinikum des Saarlandes, Homburg, Germany.
Norbert GrafPädiatrische Onkologie und Hämatologie, Universitätsklinikum des Saarlandes, Homburg, Germany.
Hans Jürgen LawsKlinik für Pädiatrische Onkologie, Hämatologie und Immunologie, Universitätskinderklinik, Heinrich-Heine-Universität, Düsseldorf, Germany.
Sebastian VoigtKlinik für Pädiatrie m. S. Onkologie / Hämatologie / Stammzelltransplantation, Charité - Universitätsmedizin Berlin, Germany.
Brar PieningInstitut für Hygiene und Umweltmedizin, Charité - Universitätsmedizin Berlin, Germany.
Christine GeffersInstitut für Hygiene und Umweltmedizin, Charité - Universitätsmedizin Berlin, Germany.
Philipp AgyemanPädiatrische Infektiologie und Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinderheilkunde, Inselspital, Bern, Switzerland.
Roland A AmmannPädiatrische Infektiologie und Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinderheilkunde, Inselspital, Bern, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pediatric patients receiving conventional chemotherapy for malignant disease face an increased risk of bloodstream infection (BSI). Since BSI may represent an acute life-threatening event in patients with profound immunosuppression, and show further negative impact on quality of life and anticancer treatment, the prevention of BSI is of paramount importance to improve and guarantee patients' safety during intensive treatment. The great majority of all pediatric cancer patients (about 85%) have a long-term central venous access catheter in use (type Broviac or Port; CVAD). Referring to the current surveillance definitions a significant proportion of all BSI in pediatric patients with febrile neutropenia is categorized as CVAD-associated BSI. This state of the art review summarizes the epidemiology and the distinct pathogen profile of BSI in pediatric cancer patients from the perspective of infection surveillance. Problems in executing the current surveillance definition in this patient population are discussed and a new concept for the surveillance of BSI in pediatric cancer patients is outlined.

Indexed as

bloodstream infectionBroviacpediatric oncologyPortsurveillance

Identifiers

PMID27274442
PMCPMC4886351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.